July/August 2017

Each Issue a Recipe

Allen C. Ho, MD, and Robert L. Avery, MD

Retina News

Medical Update

A summary of general medical news that affects your patients, your practice, and you.

Section Editor David S. Boyer, MD

Growing Pains in Retina

Tips for attending physicians entering their first ophthalmology practices from those who recently made the transition.

Christopher M. Aderman, MD; Ferhina Ali, MD; and Katherine Talcott, MD

Further Refining the Ideal Macular Hole Repair

A trifecta of articles adds new details.

Brian C. Joondeph, MD, MPS

When and How to Treat Myopic Traction Maculopathy

Surgical technique should be chosen based on detailed evaluation.

Keiko Kataoka, MD, PhD, and Hiroko Terasaki, MD, PhD

Papillophlebitis: a Closer Look

Basic awareness of a rare condition may help avoid unnecessary diagnostic measures and expedite proper treatment.

Andrea Grosso, MD; Jorge I. Calzada, MD; John Randolph, MD; and Eric Sigler, MD

Updated Classification for Primary Iris Melanoma

Key characteristics of the American Joint Committee on Cancer's revised classification system.

Vladislav P. Bekerman, BS; Maura Di Nicola, MD; Jerry A. Shields, MD; and Carol L. Shields, MD

Heads-up 3-D Visualization in Complex Vitreoretinal Surgery

The latest dimension in surgical viewing works well in many scenarios, including complex cases.

Maxwell S. Stem, MD; Aristomenis Thanos, MD; Dean Eliott, MD; Kimberly A. Drenser, MD, PhD; Tarek S. Hassan, MD; Alan J. Ruby, MD; George A. Williams, MD; and Yoshihiro Yonekawa, MD

Introduction

Intravitreal Monotherapy for CRVO, or Intravitreal Therapy Plus Laser?

Which approach to treatment is best for patients with CME secondary to central retinal vein occlusion?

Manrique Cordoba, MD, and Lihteh Wu, MD

Intravitreal Anti-VEGF Injection Treatment Algorithms for DME

Benefits and limitations of common approaches to managing patients with diabetic macular edema.

Christopher M. Aderman, MD, and Sunir J. Garg, MD

Anti-Integrin Therapy in Treatment of DME

Agent shows novel mechanism of action, binding in the retina to stop angiogenesis.

Peter K. Kaiser, MD

Dry AMD Pipeline: Looking to Intravitreal Therapy

Two oral drugs for nonneovascular AMD have had disappointing results in clinical trials.

Pravin U. Dugel, MD

5Q With Amy C. Schefler, MD, FACS

Amy C. Schefler, MD, FACS, is a surgeon at Retina Consultants of Houston, Blanton Eye Institute, Houston Methodist Hospital, and a surgeon at Children's Memorial Hermann Hospital, University of Texas Health Sciences.